New ultrasound method may cut unnecessary thyroid biopsies
NCT ID NCT06146764
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding contrast-enhanced ultrasound to standard ultrasound can improve the diagnosis of thyroid cancer. Researchers are comparing two scoring methods in 800 participants with thyroid nodules. The goal is to see which method better identifies cancer and reduces the need for fine-needle biopsies on benign nodules.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Contrast-enhanced ultrasound
- What this could lead to
- If successful, this could provide a more accurate way to diagnose thyroid cancer, potentially reducing the number of unnecessary biopsies.
- What could go wrong
- This is a retrospective study, not a randomized trial, so results may not apply to all patients. The methods need further validation before routine use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
RECRUITINGGuangzhou, Guangdong, 510289, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Genetic test may spare patients from unnecessary thyroid surgery
- Can AI help surgeons see thyroid cancer more clearly?
- Drug duo aims to starve thyroid tumors
- Could drug holidays improve thyroid cancer treatment?
- Glowing goggles could prevent calcium crash after thyroid surgery
- New hope for advanced thyroid cancer: drug shows tumor-shrinking promise